These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 19303163)

  • 1. Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis.
    Ripoll C; Groszmann RJ; Garcia-Tsao G; Bosch J; Grace N; Burroughs A; Planas R; Escorsell A; Garcia-Pagan JC; Makuch R; Patch D; Matloff DS;
    J Hepatol; 2009 May; 50(5):923-8. PubMed ID: 19303163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.
    Ripoll C; Groszmann R; Garcia-Tsao G; Grace N; Burroughs A; Planas R; Escorsell A; Garcia-Pagan JC; Makuch R; Patch D; Matloff DS; Bosch J;
    Gastroenterology; 2007 Aug; 133(2):481-8. PubMed ID: 17681169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of hepatic venous pressure gradient in patients with compensated chronic hepatitis C-related cirrhosis.
    Rincón D; Lo Iacono O; Tejedor M; Hernando A; Ripoll C; Catalina MV; Salcedo M; Matilla A; Senosiain M; Clemente G; Molinero LM; Albillos A; Bañares R
    Scand J Gastroenterol; 2013 Apr; 48(4):487-95. PubMed ID: 22871085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Decompensation and Outcomes in Patients With Compensated Cirrhosis and a Hepatic Venous Pressure Gradient ≥20 mm Hg.
    Jindal A; Bhardwaj A; Kumar G; Sarin SK
    Am J Gastroenterol; 2020 Oct; 115(10):1624-1633. PubMed ID: 32453061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of hepatic venous pressure gradient and endoscopic grading of esophageal varices.
    Lee E; Kim YJ; Goo DE; Yang SB; Kim HJ; Jang JY; Jeong SW
    World J Gastroenterol; 2016 Mar; 22(11):3212-9. PubMed ID: 27003998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of acute hemodynamic response to i.v. propranolol in patients with cirrhosis and portal hypertension.
    La Mura V; Abraldes JG; Raffa S; Retto O; Berzigotti A; García-Pagán JC; Bosch J
    J Hepatol; 2009 Aug; 51(2):279-87. PubMed ID: 19501930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic venous pressure gradient in cirrhosis: correlation with the size of varices, bleeding, ascites, and child's status.
    Wadhawan M; Dubey S; Sharma BC; Sarin SK; Sarin SK
    Dig Dis Sci; 2006 Dec; 51(12):2264-9. PubMed ID: 17080245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Measurement of hepatic venous pressure gradient in liver cirrhosis: relationship with the status of cirrhosis, varices, and ascites in Korea].
    Kim MY; Baik SK; Suk KT; Yea CJ; Lee IY; Kim JW; Cha SH; Kim YJ; Um SH; Han KH
    Korean J Hepatol; 2008 Jun; 14(2):150-8. PubMed ID: 18617762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic venous pressure gradient in the assessment of portal hypertension before liver resection in patients with cirrhosis.
    Boleslawski E; Petrovai G; Truant S; Dharancy S; Duhamel A; Salleron J; Deltenre P; Lebuffe G; Mathurin P; Pruvot FR
    Br J Surg; 2012 Jun; 99(6):855-63. PubMed ID: 22508371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-invasive aspartate aminotransferase to platelet ratio index correlates well with invasive hepatic venous pressure gradient in cirrhosis.
    Kirnake V; Arora A; Sharma P; Goyal M; Chawlani R; Toshniwal J; Kumar A
    Indian J Gastroenterol; 2018 Jul; 37(4):335-341. PubMed ID: 30178093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of worsening portal hypertension during long-term medical treatment in patients with cirrhosis who had been classified as early good-responders on haemodynamic criteria.
    Merkel C; Bolognesi M; Berzigotti A; Amodio P; Cavasin L; Casarotto IM; Zoli M; Gatta A
    J Hepatol; 2010 Jan; 52(1):45-53. PubMed ID: 19914730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting portal hypertension and variceal bleeding using non-invasive measurements of metabolic variables.
    Eslam M; Ampuero J; Jover M; Abd-Elhalim H; Rincon D; Shatat M; Camacho I; Kamal A; Lo Iacono O; Nasr Z; Grande L; Banares R; Khattab MA; Romero-Gomez M
    Ann Hepatol; 2013; 12(4):588-98. PubMed ID: 23813137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of hepatic venous pressure gradient measurement before liver resection for hepatocellular carcinoma.
    Stremitzer S; Tamandl D; Kaczirek K; Maresch J; Abbasov B; Payer BA; Ferlitsch A; Gruenberger T
    Br J Surg; 2011 Dec; 98(12):1752-8. PubMed ID: 22009385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of ascites in compensated cirrhosis with severe portal hypertension treated with β-blockers.
    Hernández-Gea V; Aracil C; Colomo A; Garupera I; Poca M; Torras X; Miñana J; Guarner C; Villanueva C
    Am J Gastroenterol; 2012 Mar; 107(3):418-27. PubMed ID: 22334252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis of 833 times measured hepatic venous pressure gradient].
    Zhang MY; Wang GC; Huang GJ; Feng H; Wang LF; Zhang JY; Shi YJ; Zhang CQ
    Zhonghua Gan Zang Bing Za Zhi; 2018 Apr; 26(4):266-270. PubMed ID: 29996337
    [No Abstract]   [Full Text] [Related]  

  • 16. β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial.
    Villanueva C; Albillos A; Genescà J; Garcia-Pagan JC; Calleja JL; Aracil C; Bañares R; Morillas RM; Poca M; Peñas B; Augustin S; Abraldes JG; Alvarado E; Torres F; Bosch J
    Lancet; 2019 Apr; 393(10181):1597-1608. PubMed ID: 30910320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between indocyanine green retention test, decompensation and survival in patients with Child-Pugh A cirrhosis and portal hypertension.
    Lisotti A; Azzaroli F; Cucchetti A; Buonfiglioli F; Cecinato P; Calvanese C; Simoni P; Arena R; Montagnani M; Golfieri R; Colecchia A; Festi D; Mazzella G
    Liver Int; 2016 Sep; 36(9):1313-21. PubMed ID: 26786880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Good performance of liver stiffness measurement in the prediction of postoperative hepatic decompensation in patients with cirrhosis complicated with hepatocellular carcinoma.
    Procopet B; Fischer P; Horhat A; Mois E; Stefanescu H; Comsa M; Graur F; Bartos A; Lupsor-Platon M; Badea R; Grigorescu M; Tantau M; Sparchez Z; Al Hajjar N
    Med Ultrason; 2018 Aug; 20(3):272-277. PubMed ID: 30167578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The New Cutoff Value of the Hepatic Venous Pressure Gradient on Predicting Long-Term Survival in Cirrhotic Patients.
    Kim TY; Suk KT; Jeong SW; Ryu T; Kim DJ; Baik SK; Sohn JH; Jeong WK; Choi E; Jang JY; Kim MY
    J Korean Med Sci; 2019 Aug; 34(33):e223. PubMed ID: 31436052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver stiffness accurately predicts portal hypertension related complications in patients with chronic liver disease: a prospective study.
    Robic MA; Procopet B; Métivier S; Péron JM; Selves J; Vinel JP; Bureau C
    J Hepatol; 2011 Nov; 55(5):1017-24. PubMed ID: 21354450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.